Download PDF
NOTARZT 2019; 35(04): 195-198
DOI: 10.1055/a-0891-6315
Pro & Contra
Georg Thieme Verlag KG Stuttgart · New York

Etomidat in der Notfallmedizin – Pro und Contra

Joachim Schmidt
1   Prof. Dr. med., Anästhesiologische Klinik, Universitätsklinikum Erlangen
,
Jürgen Schüttler
1   Prof. Dr. med., Anästhesiologische Klinik, Universitätsklinikum Erlangen
,
Jürgen Knapp
2   PD Dr. med., Universitätsklinik für Anästhesiologie und Schmerztherapie, Universitätsspital Bern, Schweiz
,
Michael Bernhard
3   PD Dr. med., Zentrale Notaufnahme, Universitätsklinikum Düsseldorf
› Author Affiliations
Further Information

Publication History

Publication Date:
13 August 2019 (online)

Also available at
    Permissions and Reprints

Kaum ein Medikament in der prähospitalen Notfallmedizin ist so umstritten und dennoch so weit verbreitet wie das Hypnotikum Etomidat. Regelmäßig kommt es zu „heißen“ Diskussionen und Kollegen zitieren Studien, die eindeutige Ergebnisse zeigen würden. Leider ist in der Medizin und insbesondere in der Notfallmedizin selten die Datenlage klar und erlaubt nur eine Interpretation. Im folgenden Artikel sollen daher Argumente für und gegen den Einsatz von Etomidat in der Notfallmedizin im Sinne einer Pro- und Contra-Debatte dargestellt und diskutiert werden. So kann sich jeder Leser sein eigenes Bild über die aktuelle Studienlage zu diesem Medikament machen und für die eigene Praxis entsprechende Konsequenzen ziehen.
 

  • Literatur

  • 1 Hohl CM, Kelly-Smith CH, Yeung TC. et al. The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: a systematic review. Ann Emerg Med 2010; 56: 105-113.e5
    CrossrefPubMedGoogle Scholar
  • 2 van den Heuvel I, Wurmb TE, Böttiger BW. et al. Pros and cons of etomidate – more discussion than evidence?. Curr Opin Anesthesiol 2013; 26: 404-408
    CrossrefPubMedGoogle Scholar
  • 3 Schüttler J, Wilms M, Lauven PM. et al. Pharmacokinetics of etomidate in man. Anaesthesist 1980; 29: 658-961
    PubMedGoogle Scholar
  • 4 Schüttler J, Schwilden H, Stoeckel H. Infusion strategies to investigate the pharmacokinetics and pharmacodynamics of hypnotic drugs: etomidate as an example. Eur J Anaesthesiol 1985; 2: 133-142
    PubMedGoogle Scholar
  • 5 Forman SA. Clinical and molecular pharmacology of etomidate. Anesthesiology 2011; 114: 695-707
    CrossrefPubMedGoogle Scholar
  • 6 Dumps C, Bolkenius D, Halbeck E. [Etomidate for intravenous induction of anaesthesia]. Anaesthesist 2017; 66: 969-980
    CrossrefPubMedGoogle Scholar
  • 7 Hildreth AN, Mejia VA, Maxwell RA. et al. Adrenal suppression following a single dose of Etomidate for rapid sequence induction: a prospective randomized study. J Trauma 2008; 65: 573-579
    CrossrefPubMedGoogle Scholar
  • 8 Jabre P, Combes X, Lapostolle F. et al. KETASED Collaborative Study Group. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 2009; 374: 293-300
    CrossrefPubMedGoogle Scholar
  • 9 Lyon RM, Perkins ZB, Chatterjee D. et al. Significant modification of traditional rapid sequence induction improfes safety and effectiveness of pre-hospital trauma anaesthesia. Crit Care 2015; 19: 134
    CrossrefPubMedGoogle Scholar
  • 10 Warner KJ, Cuschieri J, Jurkovich GJ. et al. Single-dose Etomidate for rapid sequence induction may impact outcome after severe injury. J Trauma 2009; 67: 45-50
    CrossrefPubMedGoogle Scholar
  • 11 Trentsch H, Münzberg M, Luxen J. et al. Etomidat zur rapid sequence induction bei schwerem Trauma. Notfall Rettungsmed 2014; 17: 521-535
    CrossrefPubMedGoogle Scholar
  • 12 Deutsche Gesellschaft für Unfallchirurgie. S3-Leitlinie Polytrauma/Schwerverletzten-Behandlung. AWMF Register-Nr. 012/019. Im Internet: http://www.awmf.org/uploads/tx_szleitlinien/012-019l_S3_Polytrauma_Schwerverletzten-Behandlung_2017-08.pdf Stand: 26.05.2019
    PubMedGoogle Scholar
  • 13 Mayglothling J, Duane TM, Gibbs M. et al. Eastern Association for the Surgery of Trauma. Emergency tracheal intubation immediately following traumatic injury: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 2012; 73 (5 Suppl. 4): S333-S340
    CrossrefPubMedGoogle Scholar
  • 14 Sprung CL, Annane D, Keh D. et al. CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358: 111-124
    CrossrefPubMedGoogle Scholar
  • 15 Chan CM, Mitchell AL, Shorr AF. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*. Crit Care Med 2012; 40: 2945-2953
    CrossrefPubMedGoogle Scholar
  • 16 Albert SG, Ariyan S, Rather A. The effect of etomidate on adrenal function in critical illness: a systematic review. Intensive Care Med 2011; 37: 901-910
    CrossrefPubMedGoogle Scholar
  • 17 Bruder EA, Ball IM, Ridi S. et al. Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients. Cochrane Database Syst Rev 2015; (01) CD010225
    PubMedGoogle Scholar
  • 18 Gu WJ, Wang F, Tang L. et al. Single-dose etomidate does not increase mortality in patients with sepsis: a systematic review and meta-analysis of randomized controlled trials and observational studies. Chest 2015; 147: 335-346
    CrossrefPubMedGoogle Scholar
  • 19 Jung B, Clavieras N, Nougaret S. et al. Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis. Crit Care 2012; 16: R224
    CrossrefPubMedGoogle Scholar
  • 20 Walsh M, Devereaux PJ, Garg AX. et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 2013; 119: 507-515
    CrossrefPubMedGoogle Scholar
  • 21 White SM, Moppett IK, Griffiths R. et al. Secondary analysis of outcomes after 11,085 hip fracture operations from the prospective UK Anaesthesia Sprint Audit of Practice (ASAP-2). Anaesthesia 2016; 71: 506-514
    CrossrefPubMedGoogle Scholar
  • 22 Reich DL, Hossain S, Krol M. et al. Predictors of hypotension after induction of general anesthesia. Anesth Analg 2005; 101: 622-628
    CrossrefPubMedGoogle Scholar
  • 23 Bendel S, Ruokonen E, Pölönen P. et al. Propofol causes more hypotension than etomidate in patients with severe aortic stenosis: a double-blind, randomized study comparing propofol and etomidate. Acta Anaesthesiol Scand 2007; 51: 284-289
    CrossrefPubMedGoogle Scholar
  • 24 Baradari AG, Alipour A, Habibi MR. et al. A randomized clinical trial comparing hemodynamic responses to ketamine-propofol combination (ketofol) versus etomidate during anesthesia induction in patients with left ventricular dysfunction undergoing coronary artery bypass graft surgery. Arch Med Sci 2017; 13: 1102-1110
    PubMedGoogle Scholar
  • 25 Kaushal RP, Vatal A, Pathak R. Effect of etomidate and propofol induction on hemodynamic and endocrine response in patients undergoing coronary artery bypass grafting/mitral valve and aortic valve replacement surgery on cardiopulmonary bypass. Ann Card Anaesth 2015; 18: 172-178
    CrossrefPubMedGoogle Scholar
  • 26 Cheong KF, Choy JM. Sevoflurane-fentanyl versus etomidate-fentanyl for anesthetic induction in coronary artery bypass graft surgery patients. J Cardiothorac Vasc Anesth 2000; 14: 421-424
    CrossrefPubMedGoogle Scholar
  • 27 Bernhard M, Bein B, Böttiger BW. et al. Handlungsempfehlungen zur prähospitalen Notfallnarkose beim Erwachsenen. Notfall Rettungsmed 2015; 18: 395-412
    CrossrefPubMedGoogle Scholar
  • 28 Wagner CE, Bick JS, Johnson D. et al. Etomidate use and postoperative outcomes among cardiac surgery patients. Anesthesiology 2014; 120: 579-589
    CrossrefPubMedGoogle Scholar
  • 29 Heinrich S, Schmidt J, Ackermann A. et al. Comparison of clinical outcome variables in patients with and without etomidate-facilitated anesthesia induction ahead of major cardiac surgery: a retrospective analysis. Crit Care 2014; 18: R150
    CrossrefPubMedGoogle Scholar
  • 30 Komatsu R, Makarova N, You J. et al. Etomidate and the Risk of Complications After Cardiac Surgery: A Retrospective Cohort Analysis. J Cardiothorac Vasc Anesth 2016; 30: 1516-1522
    CrossrefPubMedGoogle Scholar
  • 31 De Jong A, Jaber S. Etomidate for anesthesia induction: friends or foe in major cardiac surgery?. Crit Care 2014; 18: 560
    CrossrefPubMedGoogle Scholar
  • 32 Reinhart K, Brunkhorst FM, Bone HG. et al. [Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2 k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)]. Anaesthesist 2010; 59: 347-370
    CrossrefPubMedGoogle Scholar
  • 33 Vinclair M, Broux C, Faure P. et al. Duration of adrenal inhibition following a single dose of Etomidat in critically ill patients. Intensive Care Med 2008; 34: 714-719
    CrossrefPubMedGoogle Scholar
  • 34 Cuthbertson BH, Sprung CL, Annane D. et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009; 35: 1868-1876
    CrossrefPubMedGoogle Scholar
  • 35 Hossfeld B, Bein B, Boettiger BW. et al. Recommended practice for out-of-hospital emergency anaesthesia in adults: Statement from the Out-of-Hospital Emergency Anaesthesia Working Group of the Emergency Medicine Research Group of the German Society of Anaesthesiology and Intensive Care. Eur J Anaesthesiol 2016; 33: 881-897
    CrossrefPubMedGoogle Scholar